#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/news/30404564

British Prime Minister Boris Johnson is offering two at-home coronavirus tests a week to everyone in England

InternationalApr 06. 2021British Prime Minister Boris Johnson

By The Washington Post · William Booth

LONDON – The British government announced Monday that it will offer every citizen in England two at-home rapid coronavirus tests a week, in an audacious, costly bid to reopen the economy while avoiding another wave of infections.

Prime Minister Boris Johnson is betting that relentless, repeated testing for as many people as possible – including those who feel perfectly fine – will help break transmission chains, limit future outbreaks, and get people back to work, sporting events, theaters and normal life.

The country’s fast-moving vaccination campaign has administered at least one dose to nearly half the population, but adults under 50 in England could still be waiting until May for their first jab, and scientists don’t yet know how easily vaccinated people can transmit the virus. So the ability to test and trace is still seen as critical to keeping the virus in check.

The prime minister promised the free, simple tests will help “to stop outbreaks in their tracks, so we can get back to seeing the people we love and doing the things we enjoy.”

But questions remain about who will bother to take the tests. The United States has seen a dramatic decline in demand for testing, as the public instead looks to vaccines as the way to end the pandemic.

And if the self-administered tests show an infection, will people accurately report that to the government and then stay home? A recent review in the BMJ, a medical journal, found that only 42% of symptomatic Britons were following isolation rules.

Many in Britain are also concerned that Johnson’s mass testing will soon dovetail with a parallel effort to create “covid status certificates,” or vaccine passports.

The certificates – which would probably appear on a mobile phone app – would show whether an individual has been vaccinated, recently tested negative for the virus or has natural immunity due to previous infection within the past six months. These data would come from the public health service and self-reports.

The government said Monday that the certificates could be useful for mass gatherings, and it will begin experimenting with them for attendance at an upcoming comedy festival and a few sporting events. Johnson dismissed the idea they would be needed to enter a shop or pub garden.

Still, there continues to be strong opposition. One reporter asked at Monday’s news conference whether such documents were un-British. More than 70 members of Parliament have launched a campaign to oppose them.

Britain is slowly exiting its third national lockdown. A week from now, England will reopen nonessential shops, gyms, hair salons and barber shops, and pubs and restaurants will be allowed to serve meals and drinks outdoors.

“As we continue to make good progress on our vaccine program and with our road map cautiously easing restrictions underway, regular rapid testing is even more important to make sure those efforts are not wasted,” Johnson said.

Starting Friday, people in England will be offered lateral flow testing kits, which can be used at home, with nasal and throat swabs, and give results in less than 30 minutes. The regional governments in Northern Ireland, Scotland and Wales may soon follow.

The tests can be ordered through the mail from National Health Service (NHS) or picked up at pharmacies or testing centers, or from employers.

Speaking on the BBC, Health Minister Edward Argar said the tests would be paid for by a $50 billion NHS fund to support its test-and-trace effort, which has struggled.

The program remains controversial among some scientists, who question whether the cost and effort are worth it. They say that without better incentives for people who test positive to stay at home, most will not. They also warn of the potentially large number of cases missed by the tests, which are far speedier but less accurate than polymerase chain reaction (PCR) tests. A mass testing experiment in Liverpool last year showed the rapid test kits most widely used in Britain missed more than half of infections in asymptomatic people.

Supporters of mass testing say it doesn’t really matter – on a population scale – whether the tests miss some cases, as long as they help alert a large number of people with no symptoms that they might be infected and persuade them to stay home.

Those who test positive will be told to self-isolate, along with their household. They will also be encouraged to get a more accurate PCR test, and if that one says they are not infected, then they are free to go about their lives.

The program to mass test the population was first floated last year as “Operation Moonshot,” a plan to test 10 million people a day, or everyone in the country every week, at a cost of $130 billion. That program envisioned people being tested before they go to work, attend sporting matches or other mass gatherings.

At that time, many scientists were skeptical. “This is not going to work,” said Jon Deeks, a professor of biostatistics at the University of Birmingham, who dismissed Moonshot as the work of bureaucrats and consultants, not scientists.

Giving 10 million tests a day would certainly be a stretch. Currently, Britain records 1.2 million daily tests.

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/news/30404563

Robert Mundell, Nobel laureate who inspired the euro, dies at 88

InternationalApr 06. 2021Robert Mundell

By Syndication Washington Post, Bloomberg · Nancy Moran, Shobhana Chandra

Robert Mundell, the Nobel Prize-winner and supply-side economist who was considered the intellectual father of the euro, has died. He was 88.

His death was confirmed by Sophia Johnson, assistant director of the program for economic research at Columbia University, where Mundell was professor emeritus.

A Columbia University professor of economics, Mundell won the Nobel Prize in economics in 1999 for his theory that flexible markets, including the free movement of labor and capital, are necessary for a single-currency zone to succeed. His research helped lay the foundation for the euro, set up by 11 European governments earlier that year.

“The political glue inside Europe to keep it together — the euro — is the best thing going for it since the creation of the Common Market,” Mundell said in a 2012 interview with Bloomberg. “The end game is going to be deeper integration in Europe and more centralization of the fiscal authority.”

Mundell was also considered an architect of supply-side economics, primarily focused on the lowering of marginal tax rates to incentivize the production and consumption of goods and services. President Ronald Reagan embraced that philosophy in the form of tax cuts and inflation control that helped produce economic growth of 7.3% in 1984, the strongest in three decades.

An advocate of free markets, open trade and limited government, Mundell supported fixed-exchange rates. In 2009, in the aftermath of the world’s worst recession since the 1930s, he renewed his call for the European currency to be fixed against the dollar, saying exchange-rate swings had caused imbalances that led to the global financial crisis.

His views diverged with the late Milton Friedman, also a Nobel winner, who said that flexible exchange rates are more conducive to trade because they adjust automatically while letting a country control its own money supply.

Later in his career, Mundell proposed a world currency, the “DEY” — a basket of U.S. dollars, euros and yen — as a way to stabilize financial markets under a new international monetary system.

In the early 1960s, he laid out independently, with the late Marcus Fleming, a model that asserts a country can’t simultaneously pursue a fixed exchange rate, free capital flows and an independent monetary policy — the “impossible trinity.”

The most relevant aspect of his work was the theoretical cornerstone for the euro. Europe needed unifying frameworks and institutions, such as the Economic and Monetary Union established by the 1991 Maastricht Treaty, to foster peace on the continent and compete with the U.S. and China. The euro, considered the biggest economic experiment of the 21st century, took the region’s economic and political integration to the next level.

“It’s very difficult to attribute such a complex project to a single person, but certainly in terms of intellectual inspiration, he has played a very important role,” former European Central Bank board member Lorenzo Bini Smaghi said in a February 2016 interview.

Robert Alexander Mundell was born Oct. 24, 1932, in Kingston, Ontario, in Canada, one of four sons to William Mundell and the former Lila Knifton. He received a bachelor’s degree from the University of British Columbia in 1953 and his masters a year later from the University of Washington in Seattle, according to Marquis Who’s Who.

In 1956, he earned his Ph.D. in economics from the Massachusetts Institute of Technology and also became a postdoctoral fellow in political economics at the University of Chicago, where he met Friedman.

His academic career included stints at the University of British Columbia, Stanford University, the University of Chicago and Geneva’s Graduate Institute of International Studies. In 1974, he joined Columbia University.

Mundell advised the United Nations, the International Monetary Fund and the World Bank, and was also a consultant to governments in the U.S., Canada, Latin America and China.

He was an outspoken critic on economic and political issues. In November 2008, he questioned President-elect Barack Obama’s plan to raise U.S. income taxes for the highest earners, proposing instead a cut in corporate taxes to as low as 15% from 35%.

In December 2009, he said that Federal Reserve policies had helped trigger the collapse of Lehman Brothers Holdings Inc. by allowing the dollar to rise in the months before the investment bank’s bankruptcy. A year later, he criticized the Fed’s unconventional monetary policy actions, arguing it had been “negligent” in not anticipating so-called quantitative easing would have the undesired effect of pushing up the dollar.

Mundell was prepared for Europe’s economic and currency union to be an ongoing process, and “he understood perfectly that you wouldn’t have the perfect euro from the start,” Bini Smaghi said.

“In facilitating the agglomeration of the European economies to rival those of the U.S. and China, Mundell’s work was critical,” said Stephen Jen, co-founder and chief executive of London-based Eurizon SLJ Capital and a former IMF economist.

Mundell was also an early advocate of getting the IMF to consider adding China’s yuan to its Special Drawing Rights valuation basket, predicting it would eventually become a reserve currency. The yuan eventually won that status from the institution in November 2015.

Mundell and his first wife, Barbara Sheff, had three children: Paul, William and Robyn. After the couple the divorced, he married Valerie Natsios in 1998 and they had a son, Nicholas, according to Who’s Who.

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/news/30404562

Dollar keeps Citigroup, Morgan Stanley wary of emerging markets

InternationalApr 06. 2021Shoppers wearing protective face masks walk down a street full of shops selling textiles and clothing garments in Istanbul, Turkey, on Thursday, Aug. 27, 2020. MUST CREDIT: Bloomberg photo by Nicole Tung

By Syndication Washington Post, Bloomberg · Netty Ismail, Lilian Karunungan, Sydney Maki

Emerging-market investors reeling from last month’s losses head into the first full week of April bracing for more pain driven by higher U.S. Treasury yields and a stronger dollar.

Stronger-than-expected U.S. jobs data on Friday prompted traders to price in an earlier start to Federal Reserve interest-rate increases. That’s fueling concern the higher returns offered for risk-free investments in the world’s largest economy may drive even more money away from emerging markets. Demand for developing-nation assets waned in March, with flows to equity funds falling to less than a third of the levels seen in February and bond funds seeing outflows, according to EPFR Global data.

Morgan Stanley is staying bearish on emerging-market currencies, saying the slow pace of vaccine rollouts in many developing economies is threatening to ensure growth will lag behind the U.S.

Meantime, Citigroup expects higher U.S. yields and a resilient dollar to put further pressure on the asset class in the coming months.

“This quarter can be big for the dollar and not necessarily amazing for emerging markets,” said Luis Costa, Citigroup’s London-based head of CEEMEA strategy. “We don’t believe the U.S. curve is pretty much done adjusting. Between now and June/July, we could see a further leg higher here in yields.”

Developing-nation currencies and bonds posted their first quarterly decline in a year in the three months ending March 31, while the dollar approached its strongest level since November. Stocks slid for the first month since September, paring their gains for the quarter.

Investors will turn their attention this week to inflation data across emerging markets as they seek clues on the path for monetary policy after Turkey, Russia and Brazil raised borrowing costs last month.

– – –

Price Pressures:

– Turkey’s inflation accelerated as expected to an annual 16.2% in March, up from 15.6% the previous month. That leaves the new central bank chief little room to enact the interest-rate cuts that would mollify President Recep Tayyip Erdogan. Central bank Governor Sahap Kavcioglu signaled last week he wouldn’t stray from his predecessor’s hawkish policies.

– Russia’s inflation probably accelerated to 5.8% in March, when the central bank raised interest rates in an effort to combat the effects of ruble weakness and rising food prices. The ruble was the worst-performing emerging-market currency last week amid concerns over U.S. sanctions.

– Colombian inflation data, scheduled for Monday, may show a slowdown in March and push traders to trim odds of a tightening cycle starting this year.

– While Chile’s March inflation figures on Thursday may flag an increase from a month prior, investors will be more focused on what a renewed lockdown in the nation’s capital means for a recovery. Chile’s vaccine rollout has been the quickest in the region, yet peso bulls are eyeing near-term risk as covid cases reach record levels.

– Mexico will release both March CPI data and central bank meeting minutes Thursday, offering clues on the monetary authority’s plans. Data-dependent policy makers kept the key rate at 4% in March given an uptick in consumer prices. Industrial production figures for February are set to be posted Friday.

– Thailand on Monday reported consumer prices fell 0.08% in March from a year ago. The Philippines, Taiwan and China are due to report similar data on Tuesday, Thursday and Friday, respectively. China’s producer price index probably rose to the highest in more than two years last month, according to economists. Quickening price growth is raising concern the country will export inflation globally given its role as manufacturer to the world. Philippine inflation is expected to remain above the central bank’s 2% to 4% target band for a third month due to rising food prices. The peso has fallen 1% this year

– – –

Central Banks on Hold:

– India’s central bank will keep interest rates at a record low when policy makers meet Wednesday, according to all of the economists surveyed by Bloomberg. Bond traders pared bets that the central bank will shift to a tighter policy stance as early as this year after the nation reported a record jump in coronavirus cases. “We will look for any guidance on possible normalization of liquidity conditions,” Rini Sen, an economist at Australia & New Zealand Banking Group in Bengaluru, wrote in a research note. “At this juncture, the financial system is in a unique environment of excess liquidity but rising long-term yields on government securities.” India’s local bonds have lost 1.3% this year in dollar terms, according to a Bloomberg Barclays index.

– Investors will watch Peru’s central bank decision on Thursday for any signs of change by the monetary authority. Borrowing costs have been steady at 0.25%, the lowest in Latin America, since last April. The nation is also scheduled to post trade balance figures for February.

– Poland’s central bank will probably keep interest rates unchanged. Polish inflation unexpectedly rose in March to the highest level since September, piling pressure on the country’s central bank to reconsider its dovish stance. The zloty strengthened against the euro last week after touching a 12-year low on March 29.

– – –

What Else to Watch:

– The International Monetary Fund and World Bank’s Spring meetings will take place virtually for a second year starting on Monday. The IMF will post its updated World Economic Outlook on Tuesday, with Managing Director Kristalina Georgieva already indicating an upgrade to January’s forecast for 5.5% global economic growth for 2021.

– South Korea’s current-account balance is due Wednesday. The won has dropped 4% this year despite a current-account surplus.

– China, Indonesia, Malaysia, Taiwan and the Philippines will all release foreign-exchange reserves data on Wednesday.

– The Philippines will publish February trade figures on Thursday.

– Taiwan’s trade statistics for March are due Friday. Robust export growth has helped the local dollar defy gains in the U.S. currency this year, weakening just 0.8%.

– In Brazil, investors will weigh the risk of spending-cap breaches as officials debate the budget. They will also watch a reading of March IPCA inflation data on Friday as the pandemic rages on.

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/news/30404528

When police kill people, they are rarely prosecuted and hard to convict

InternationalApr 05. 2021Thousands of people protest the death of George Floyd in Minneapolis on June 5, 2020. MUST CREDIT: Washington Post photo by Salwan Georges

By The Washington Post · Mark Berman

The footage plays inside the downtown Minneapolis courtroom where Derek Chauvin is on trial, charged with murder. It shows George Floyd, a Black man, gasping for air under the White police officer’s knee.

That video is the centerpiece of the case against Chauvin, which prosecutors emphasized by urging jurors to “believe your eyes.”

But prosecutors face a steep legal challenge in winning a conviction against a police officer. Despite nationwide protests, police are rarely charged when they kill someone on duty. And even when they are, convictions often are difficult.

Between 2005 and 2015, more than 1,400 officers were arrested in a violence-related act committed on duty, according to data tracked by Philip Stinson, a criminologist at Bowling Green State University. In 187 of those cases, people were fatally injured in shootings or from other causes. The officers charged represent a small fraction of the hundreds of thousands of police officers working for about 18,000 departments nationwide.

Police charged with committing violent crimes while on duty were convicted more than half the time during that period. In the most serious cases – those involving murder or manslaughter – the conviction rate was lower, about 50%.

About 6 in 10 people charged with violent crimes were convicted, according to a federal report that examined cases adjudicated in the country’s 75 most populous counties in 2009. The number increased to 70% when murder was the most serious charge. Most criminal cases in the United States end in plea bargains, rather than court trials.

Chauvin’s case is different from many of the most high-profile police prosecutions in recent memory, in part because it centers on an officer who never fired his gun, experts say.

There are a few reasons it is difficult to convict a police officer, according to legal experts and attorneys who have worked on such trials: Police have considerable leeway to use force, can cite their training and are typically trusted by juries and judges.

“The law favors the police, the law as it exists,” said David Harris, a law professor at the University of Pittsburgh and an expert in policing.

“Most people, I think, believe that it’s a slam dunk,” Harris said of the case against Chauvin. But he said, “the reality of the law and the legal system is, it’s just not.”

Attorneys who have worked both sides of these cases say they invite heightened scrutiny and raise a host of issues about the authority police have, the force they are allowed to use and the dangers they could confront on the job.

“It’s fundamentally different than handling any other kind of case,” said Neil Bruntrager, a St. Louis-based attorney who has represented officers in high-profile cases.

“We grant [police] very significant power,” Bruntrager said. “And when we see the prosecution of a police officer for a line-of-duty act . . . what we’re really talking about is not the violation of that particular law, whatever it may be, but the violation of that trust.”

A key element that experts say factors into many of the cases is the Supreme Court’s 1989 Graham v. Connor decision, which found that an officer’s actions must be judged against what a reasonable officer would do in the same situation.

“A police officer can use force, but it has to be justifiable,” Bruntrager said. “And what the Supreme Court has told us is we have to see it through the eyes of the police.”

Police shoot and kill about 1,000 people a year, according to The Washington Post’s database tracking such cases. Most of these people are armed, and most of the shootings are deemed justified. When police are charged in fatal shootings, officers are convicted less than half the time, often on lesser charges.

Chauvin’s case is unlike those in key ways, experts say. “It’ll be much harder . . . for Mr. Chauvin to claim the usual justification of self-defense than it is when there are shooting deaths,” said Kate Levine, a professor at Yeshiva University’s Benjamin N. Cardozo School of Law. “It’s very hard for him to say, ‘I was in fear for my life when I knelt on this man’s neck.’ “

When police shoot and kill someone, the officers’ descriptions of what they saw and felt – and accounts of the danger facing them or someone else – can be a major part of the defense, experts say.

“In many of the shooting cases, the officer will say, ‘I perceived a threat in the form of reaching for a gun, or an aggressive move towards me,’ ” said Rachel Harmon, a law professor at the University of Virginia. “It is difficult for the state to disprove the perception of that threat.”

In this case, Harmon said, “there’s not the same kind of ability to claim a perception of a threat.”

Chauvin’s attorney argued in his opening statement that the officers charged in Floyd’s death felt the “growing crowd” at the scene was threatening. But Chauvin’s core defense, as presented in legal filings and his attorney’s remarks in court, appears to be focused on something else: making a case that he did not actually kill Floyd.

In court filings, Chauvin’s attorneys noted Floyd’s health issues and said he “most likely died from an opioid overdose,” trying to break the chain of causation between Chauvin’s knee and Floyd’s death. Medical experts have said say they disagree with the defense’s argument.

Debates over causation have come up in other cases not involving gunfire, including when people die behind bars or after being shocked by stun guns, said Craig Futterman, a University of Chicago law professor and director of the Civil Rights and Police Accountability Project. In those cases, he said, the argument is often made that “other contributing factors,” such as drugs in someone’s system, played a role.

The invocations of Floyd’s drug use in Chauvin’s trial also echo previous cases in another way, Futterman said.

“One of the standard strategies in the playbook that I’ve seen, when police officers are accused of misconduct, are charged with killing someone, is putting the victim and the victim’s character on trial,” he said.

But it’s unclear how that might play out in an evolving environment, in which attitudes on how police use force have changed, Harmon said.

“One of the things that’s really shifted in the public debate over use of force is that many people think that there’s too much force even against people who committed crimes, and may use drugs, and may have problems in their lives,” Harmon said. “The public tolerance for the argument that the victim of misconduct or victim of police use of force has done something wrong is less broad than it once was.”

Another key shift observers said may affect these cases is the changing way people may view police officers.

Juries have typically been inclined to trust officers, who come to court with no criminal record and with experience in testifying, experts and attorneys said. But, they said, recent years of repeated viral videos of police shootings and other uses of force may have chipped away at that perception.

The wave of protests that followed Floyd’s death last year was accompanied by a decline in public approval of police, and last fall voters in several places approved more scrutiny and oversight for police in their communities.

“It’s not an easy place to be in a position where you’re defending police officers who are charged these days,” said Bruntrager, the defense attorney who represented former officer Jason Stockley in St. Louis and former officer Darren Wilson in Ferguson, Mo.

Wilson’s fatal shooting of Michael Brown, a Black 18-year-old, fueled widespread unrest in 2014 and helped lead to a years-long nationwide focus on how police use force. Before then, Bruntrager said, if police “had any kind of credible defense, people wanted to believe that . . . police were following the law.”

“Now it is the reverse,” he said. “Now it is a situation where you start out with the idea where people believe police officers are violating the trust.”

But prosecutors still worry about persuading juries to convict on the most serious charges.

When Joseph McMahon, a former Kane County, Ill., state’s attorney, was preparing to try a Chicago police officer on murder charges, his team contacted other prosecutors who had charged officers – often unsuccessfully.

These prosecutors had spoken to the juries after their cases. Again and again, McMahon said, they reported hearing the same message about the officers from jurors: ” ‘We were convinced what he did was wrong. But we weren’t convinced what he did was murder.’ “

McMahon and his team were preparing a case against Jason Van Dyke, who fatally shot Laquan McDonald, a Black 17-year-old. Video footage of the shooting, which showed the officer firing 16 shots at the teenager, set off unrest when it was released in 2015. Van Dyke was charged with murder the same day the video was released.

After speaking to other prosecutors who said jurors in their cases could not bring themselves to convict the officers of murder, McMahon said he had Van Dyke charged with another 16 counts of aggravated battery, one for each gunshot.

“I didn’t want my jury to be faced with an all or nothing decision,” said McMahon, who was named special prosecutor in the case.

If the only option facing jurors involved the word “murder” in it, McMahon said, he was worried one or two jurors might be unwilling to sign off on it. Jurors get instructions about the legal definitions of specific crimes, he said, but people might still walk in with preconceived notions of what murder is and not think an officer’s actions fit the bill.

It wound up being unnecessary, he said. The jury convicted Van Dyke on all counts in 2018, including second-degree murder.

Chauvin, who was fired after Floyd’s death, is charged with second-degree murder and second-degree manslaughter in Floyd’s death, and the judge in the case reinstated a third-degree-murder charge during jury selection.

Attorneys representing police in controversial use-of-force cases have defended them by saying that they can use force and often have to make split-second decisions in tense, potentially dangerous moments.

Police officers are only human and can get “scared like everyone else” during stressful situations, said Dan Herbert, the Chicago attorney who represented Van Dyke. “The fact of the matter is that the law recognizes that police are allowed to use force, including deadly force, in a number of situations,” he said.

Eric Nelson, Chauvin’s attorney, invoked this argument during his opening statement when he called police uses of force “not attractive” but sometimes necessary.

Herbert said it is “probably naive” for the defense in Chauvin’s case to hope it can persuade a dozen jurors to vote to acquit.

Instead, Herbert said, Chauvin’s defense probably will aim to “pick off one or two of those jurors and possibly hang the case” by having the jury deadlock. The defense’s best chance heading into the trial, he said, probably was its attempt to break the chain of causation and argue that Chauvin did not kill Floyd.

Prosecutors sought to fight the defense’s claims of an overdose by having Floyd’s girlfriend testify about his struggles with substance abuse, a testimony aimed at establishing his tolerance for opioids.

The defense’s argument on that front could appeal to someone inclined to blame Floyd, rather than the police, for what happened, said Harris, the law professor at the University of Pittsburgh. Chauvin’s team does not have much else to work with, he added.

But while the prosecution must persuade every juror to vote to convict him, the defense just needs “one juror who feels a little funny about convicting a police officer,” Harris said.

“You have the law leaning in the direction of, give police the benefit of the doubt,” he said. “That seems a difficult thing to do with this video. But if somebody had that inclination, deep down, here’s your way to exercise it.”

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/news/30404527

While Asia wants a baby boom, Indonesia says enough Is enough

InternationalApr 05. 2021A closed store at Tanah Abang market in Jakarta in August 2020. MUST CREDIT: Bloomberg photo by Dimas Ardian

By Syndication Washington Post, Bloomberg · Claire Jiao, Grace Sihombing, Michelle Jamrisko

Countries across Asia are trying everything from fertility tours to baby bonuses to spur population growth in an aging world. Not so in Indonesia, where officials are trying to convince people to have fewer children.

The world’s fourth most-populous country is promoting later marriages, family planning and contraception to lower its fertility rate to 2.1 children per woman by 2025. That’s the “replacement rate” that would effectively flatten population growth in the country of 270 million, damping some concerns that overcrowding could mean fewer job opportunities and strains on government services.

Indonesia’s latest push – a family planning campaign starting from late January – follows a decades-long struggle to bring the fertility rate down from 3 children per woman in the early 1990s. The difference now, National Population and Family Planning Agency Head Hasto Wardoyo says, is that instead of just slowing population growth, Indonesia is aiming to simultaneously improve other factors such as health, education and employment.

“In the past, the focus was on reducing the quantity of the population. Now it’s more on improving the quality of the population,” Wardoyo said. “The quality and productivity of human resources must be improved because we’re currently in a demographic dividend period. If not utilized, the demographic bonus can actually become a burden for development, rather than development capital.”

That might appear to be a risky venture for an emerging market, especially one that has lured investors with its youthful demographics and cheap labor. China famously has found it’s a struggle to reset the habits of families who for decades were restricted to one child. And development economists generally advise that overpopulation tends to resolve itself as a country climbs the income ladder, making counter-efforts unnecessary.

Indonesia is saying it can’t afford to wait, especially as it’s bracing in the short term for potentially more pregnancies and less contraceptive use amid the pandemic’s stay-at-home orders.

Like many of her friends and relatives, Yulia Purnamasari said she got pregnant right after getting married in 2018. But when she and her husband realized the time and money needed to raise a child, they delayed having another baby so they could save up for a few years.

“We think it’s a plan that fits with our capacity with time, energy and money,” the 29-year-old working mother said. “We want to be able to provide our children with our maximum attention, care and education.”

Purnamasari said she didn’t know about family planning or how to access counseling where she lives on Lombok island in eastern Indonesia. Luckily, a local midwife was able to give her advice on contraception and installed an intrauterine device.

But Purnamasari still sees herself as an exception.

“My sister, for example, doesn’t do family planning and doesn’t use contraceptives regularly,” Purnamasari said. “If she gets pregnant out of plan, she just sees it as a blessing.”

The government’s campaign to make Purnamasari less of an exception, along with emphasizing a more digital-ready workforce, seems to be winning over analysts and investors.

The drive to develop human capital “aligns with broader strategies to move Indonesia up the industrial value chain in areas like electric vehicles and downstream processing, as well as accelerating growth in what is already Asean’s largest digital economy,” said Patrick Cooke, a managing editor of research firm Oxford Business Group, referring to a group of Southeast Asian nations. “On balance, I believe investors would be happier with rising prosperity and skill levels in Indonesia rather than an ever-rising population.”

Given the size of Indonesia’s population, even a modestly higher-than-average fertility rate can balloon the numbers. At its current pace of 2.3 children per woman, Indonesia will add 30 million people in the next decade – an increment that dwarfs the total population of Australia, United Nations projections show.

The new population strategy would be a fundamental reworking of the growth model that has Indonesia on course to be one of the world’s five largest economies by 2030, overtaking the likes of Germany, Japan, Russia and Brazil, according to Standard Chartered projections from 2019 using purchasing power parity exchange rates and nominal GDP. The country has long banked on its huge domestic market for consumption, while its abundant cheap labor has propped up sectors like manufacturing, mining and agriculture.

Indonesia’s efforts contrast with regional neighbors, especially in rapidly aging Thailand and Singapore.

In Thailand, the government has embarked on a long-term campaign to avoid being a rare economy that grows old before it grows rich. The central bank has warned repeatedly that Thailand could be the first developing country to become an “aged society” by next year, and is pushing to raise the retirement age, support reverse mortgages for the elderly and give employers incentives to hire workers older than 60.

Singapore has offered to increase cash support for citizens who have kids amid reports that many could delay parenthood due to job losses and wage cuts during the pandemic. The number of marriages in the city-state fell about 10% last year.

“To secure our future, we must make our own babies, enough of them,” Singaporean Prime Minister Lee Hsien Loong said in 2019.

As Indonesia embarks on the opposite course and seeks to change attitudes, it also faces the challenge of adapting to a higher-income economy.

Despite graduating to upper-middle income status last year, Indonesia lags countries in the Organisation for Economic Cooperation and Development – a group of richer nations, where it’s a “key partner” rather than a member – across a range of development indicators like health care spending, youth employment, tertiary educational attainment and life expectancy.

The pandemic has aggravated the situation, especially as Indonesia battles Southeast Asia’s worst coronavirus outbreak. The OECD warns of “severe” social fallout even if the economy returns to growth, as shrinking job opportunities threaten to swell the ranks of the poor to 36 million.

“Even without a pandemic, Indonesia’s job market is already quite tight with around 2.5 million new entrants to the workforce each year,” said Turro Wongkaren, director at the University of Indonesia’s Institute of Demography. If the government can’t keep people healthy, educated and employed, its “demographic bonus” can just as easily become a “demographic disaster,” he said.

Bringing down the fertility rate is a long and gradual process, according to Satyawanti Mashudi, a commissioner with the National Commission on Violence Against Women. It took the country more than two decades to lower the fertility rate from around 3 children per woman in 1991 to 2.4 in 2017, she said.

“As populations get wealthier they tend to have less kids, as they don’t rely on them when they are older and it becomes more expensive for education and other needs,” said Joshua Crabb, a senior money manager at Robeco in Hong Kong. “This is indicative of a growing middle class and a focus on the quality of life. Either way, it will be many years before that would impact the demographics of Indonesia, which is still very young.”

There are also deeply ingrained cultural and religious values at play. The predominantly Muslim nation has tight-knit extended families, and having more children is considered to bring more blessings from God, Mashudi said. Even when women are open to contraception, their husbands and relatives may not be supportive, she said.

The government also will have to confront a more-is-more mindset among Indonesian families, especially those in the provinces that still consider children as potential human capital for their businesses, Mashudi said.

“I once talked to a person in Kalimantan island about family planning and they said, ‘Why should I have fewer children? My family still has this large plot of land, so why should we have a small family?'”

Some say Indonesia may not have to do much at all. Fertility rates are falling across the world, although the pace is slower in Indonesia.

Potent socioeconomic forces such as rapid urbanization, rising incomes, and improving female education and labor participation are giving rise to smaller families, Asian Development Bank principal economist Donghyun Park said.

Indonesia would do well to prepare for the shift and invest in improving the productivity and innovation of its human capital, especially amid its “gaping shortage” of technical and professional skills, Park said.

Years of inadequate investment in education have led to a deficit of 1.3 million high-skilled workers in 2020, OECD data showed. The gap is estimated to grow to 3.8 million by 2030, equivalent to one-third of the high-skilled workforce.

ADB’s Park said Indonesia eventually will need to shift away from a growth paradigm of low-wage employment toward one geared for a higher-value knowledge economy.

“In short, Indonesia’s future growth model envisions better workers instead of more workers,” Park said.

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/news/30404526

World’s biggest wind farm may be answer to South Korea’s net-zero dream

InternationalApr 05. 2021Wind turbines manufactured by Doosan Heavy Industries & Construction Co. and the offshore substation stand at the Korea Offshore Wind Power wind farm in Buan, South Korea, on Thursday, March 25, 2021. MUST CREDIT: Bloomberg photo by SeongJoon Cho.

By Syndication Washington Post, Bloomberg · Heesu Lee, Will Mathis

The fishing grounds where Jung Kuenbae and his forbears have caught shrimp, butterfish and croakers for three generations are going to be turned into the world’s largest offshore wind farm. He’s okay with that.

“I initially opposed the idea when the plan was proposed because it will destroy our livelihood,” said Jung, who leads a group of local fishermen in some 200 ships that drop nets in the waters off the southwestern tip of the Korean peninsula. “But I realized the project is part of the country’s transition to cleaner energy, which is something we have to come to terms with, rather than fighting against it.”

The 48.5 trillion won ($42.8 billion) wind farm, to be built over the next decade off the southwest coast of the country, would generate up to 8.2 gigawatts of power, one of a catalog of grand projects the government wants to roll out with private sector backing to meet its ambition of becoming carbon neutral by 2050.

It’s a momentous challenge. South Korea’s industrial ascent since the 1960s has made it one of the world’s top 10 energy users, with electricity consumption per capita ahead of both Japan and Germany. And two thirds of that comes from fossil fuels. Renewable energy accounted for only 6.5% of South Korea’s generation in 2019, with nuclear making up the balance.

“South Korea will have to source almost all of its electricity from renewable energy if it’s ever going to reach climate neutrality by 2050,” said Lee Sanghoon, president of the New and Renewable Energy Center at Korea Energy Agency. It “is a daunting task.”

Many countries are scaling up wind energy. Developers set a record last year as they installed 96.3 gigawatts of wind turbines globally, according to clean energy research group BloombergNEF. That would be enough to power about 36 million American households. The International Energy Agency estimates that at least 160 gigawatts of wind has to be added per year by 2025 in order to meet the Paris Agreement’s goals.

After retaining power last year on the promise of a “Green New Deal,” President Moon Jae-in’s Democratic Party has brought a new urgency to the transition, with a proposal to get more than 20% of its energy from renewables by 2030. For South Korea, it’s not just about curbing emissions. Apart from a tiny amount of gas and coal, all its fossil fuels are imported, costing the nation $73 billion a year.

With its conventional hydropower resources almost fully utilized and a climate and topography ill-suited for large solar and onshore wind plants, the country is looking out to sea to solve the problem. It already has the world’s biggest tidal power plant at Sihwa Lake. But the government sees one of its best prospects is to harness 12 GW from offshore wind by 2030, compared with less than 0.2 GW now.

The open seas have more consistent wind speeds and provide space to install the biggest, most efficient turbines. Just by using sites in shallow water that are near to shore, the world could get enough electricity to meet all global demand. With floating turbines that go further out to sea, wind power could satisfy more than 10 times the world’s total electricity demand by 2040, an IEA analysis showed.

So far countries in northern Europe such as the U.K., Denmark and Germany have dominated the offshore wind industry, thanks to generous government subsidies and unusually shallow waters of the North Sea. But that’s starting to change. Last year China installed a record-number of offshore wind turbines to become the world leader in total capacity. U.S. President Joe Biden’s administration plans to rapidly scale up wind farms off the east coast.

About 80 miles from the Korean island of Shinan, where the fisherman Jung lives, maintenance workers in helmets and orange life jackets climb a 200 meter-tall tower at the nation’s biggest existing commercial offshore wind farm, 30 minutes by boat from the port of Buan. The project’s 60 MW capacity is less than 1% of the proposed new wind farm in Shinan.

The complex, in the Southwest Sea, will be expanded to 2.46 GW after 2027, according to Korea Offshore Wind Power Corp., a special purpose company formed by state-run Korea Electric Power Corp. and six other generators.

One of the major challenges to achieving these goals is local opposition. A BloombergNEF report in September predicted that South Korea could fall short of the government’s target wind power by 4.6 GW, mainly due to “severe opposition” from local residents.

To ease conflict with the community, the Shinan government in 2018 passed rules allowing them to acquire a 30% stake in local renewable energy projects. That will provide a windfall for residents of six of the islands in the archipelago this month when last year’s profits from two solar plants are distributed.

“Renewable energy will become a stable source of income for Shinan residents, who are mostly in their 70s and 80s,” said Kim Jung Dae, a 63-year-old farmer who represents a group of local residents. “I wouldn’t be surprised if Shinan became the most well-off island in the country.”

There are other challenges. Wind power in South Korea currently costs about $220 per megawatt hour, according to IHS Markit, among the highest in the world.

“You’d need the wind to blow at 13 meters per second all day every day to run at full capacity of 8.2 gigawatts, which is impossible,” said Joo Han Gyu, a professor at Seoul National University’s department of nuclear engineering. “The economics of these wind turbines make no sense and the increased cost will eventually fall upon individuals.”

South Korea’s wind ambitions also rely on a sustained effort from dozens of private companies. The Shinan wind project, for example, is composed of about 20 separate ventures by corporations including SK E&S Co. and Hanwha Engineering & Construction. That means plans could get scrapped or modified as each company goes through the long process of obtaining permits and calculating costs.

To help accelerate installations, a “one-stop shop” bill will be proposed in the first half of this year that will allow the government to take the helm in exploring potential offshore sites and getting required permits, said Yoon Sunghyuk, a director of the renewable energy division at the Ministry of Trade, Industry and Energy.

One answer may be to develop floating plants that can be moored further out than fixed turbines, which are limited to shallow water, said Lee from the Korea Energy Agency. Several such projects are planned by companies including Korea National Oil Corp. and Equinor ASA, which aim to jointly construct a 200-megawatt complex in the East Sea near Ulsan.

For Jung, sitting in his office in Mokpo, the country’s interest in offshore wind has led him to see the energy transition as an opportunity, rather than the end of his career.

“No one knows the sea here better than us. I’m sure there will be plenty of work we can do,” Jung said. “If you can’t turn the tide, it’s better to embrace the flow.”

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/news/30404525

Biden vaccination goal stands despite plant contamination, White House says

InternationalApr 05. 2021

By The Washington Post · Amy Goldstein, Jon Swaine, Christopher Rowland

WASHINGTON – The Biden administration said Sunday that the country will have sufficient coronavirus vaccine supply to meet the president’s goal of enabling every adult in the United States to get immunized by the end of May, despite the contamination of millions of doses at a troubled Baltimore manufacturing facility.

A senior administration official, who spoke on the condition of anonymity to discuss the sensitive matter, said health officials had negotiated for more than a week for an arrangement, announced late Saturday, under which Johnson & Johnson would take over responsibility for manufacturing at the plant. Johnson & Johnson developed one of the two coronavirus vaccines being made at the Baltimore facility where the cross-contamination occurred.

Federal officials were working over the weekend to pin down another U.S. site where the other vaccine produced in the facility – developed by AstraZeneca – could be manufactured and have identified potential locations.

Meanwhile, the company that owns the plant, Emergent BioSolutions, may be allowed to retain some of its employees in making the Johnson & Johnson vaccine, as long as it relinquishes all control of the manufacturing and quality inspections, the official said. Emergent Biosolutions is a major government contractor.

The developments followed the news that a batch amounting to 15 million doses of Johnson & Johnson’s vaccine was spoiled at the Emergent plant after being contaminated with ingredients for AstraZeneca’s vaccine.

The error was caught, and no contaminated vaccine left the plant, according to the companies involved. No doses had shipped, because the plant has not yet been certified by the Food and Drug Administration as a manufacturer of coronavirus vaccine.

When President Joe Biden took office in January, his administration inherited a scarcity of the two vaccines that the FDA had by then authorized for emergency use against the novel coronavirus, which can cause the illness covid-19. Those vaccines were developed by Pfizer-BioNTech and Moderna. Johnson & Johnson’s was authorized in late February.

The president and his aides have prioritized increasing vaccine supplies. A month ago, Biden pledged that stepped-up vaccine manufacturing would lead to enough doses for every adult who wanted one by the end of May.

On Sunday, the senior official said that, no matter what happens with the Baltimore plant or the manufacturing of AstraZeneca vaccine, which is not authorized for U.S. use, “there is enough vaccine for all adult Americans who want it by May 31.”

Federal rules specify that “live vector” vaccines should not be made at the same facility, but the official said it had been ambiguous whether the rule applies to the type of vaccines developed by Johnson & Johnson and by AstraZeneca, or whether two vaccines could be made in separate areas of a plant. “They proved they can’t,” the official said.

That official and two other administration officials who also spoke on the condition of anonymity to discuss the sensitive situation said that, in deciding which vaccine should continue at the Emergent facility, the Department of Health and Human Services chose to keep Johnson & Johnson because those shots could be used in the United States if the FDA certifies the plant for that use.

According to the officials, the Biden administration negotiated a path out of the plant’s contamination troubles without explicitly invoking the Defense Production Act, a 1950s-era law that has been used to accelerate vaccine-making material and other coronavirus-fighting supplies.

Johnson & Johnson said in a statement Saturday that it “is adding dedicated leaders for operations and quality, and significantly increasing the number of manufacturing, quality and technical operations personnel to work with the company specialists already at Emergent.”

The company said it expects to deliver 100 million doses of its single-shot vaccine to the U.S. government by the end of May.

Emergent spokeswoman Nina DeLorenzo said the company intends to stop making the AstraZeneca vaccine in the next few days.

AstraZeneca said in a statement that it is working with the federal government “to support agreed-upon plans for the development, production and full delivery of the vaccine.”

AstraZeneca did not say how much its departure from the Emergent plant could set back its manufacturing timeline in the United States. It has taken other manufacturers six months or more to ramp up new supply of coronavirus vaccine lines.

Unrelated to the contamination by Emergent employees, AstraZeneca already has been beset by problems with clinical trials, controversy over reporting of its data, and concerns in Europe about blood clots showing up as a rare side effect. In May 2020, the company predicted that it would begin delivering the first of 300 million doses of its vaccine for the United States in the fall, but it did not meet that promise, nor has the FDA authorized it for emergency use.

For Emergent to spoil raw vaccine substance amounting to 15 million doses suggests a breakdown in quality control at early stages of manufacturing that should have been caught in subsequent steps, said John Avellanet, an FDA compliance expert who is managing director at Cerulean Associates, a pharmaceutical consulting firm.

If contamination had been detected earlier in the process, he said, it probably would have affected far less product. Johnson & Johnson had said last year that Emergent would be making vaccine in single-use, 1,000-liter bioreactor bags. The magnitude of this incident indicates that more than one bag’s product was probably affected, Avellanet said, adding that it was highly unusual for so much vaccine substance to be ruined in one incident.

“This kind of thing just does not happen,” Avallenet said.

The changes in vaccine production at the plant were first reported Saturday by The New York Times.

The Washington Post reported last week that an FDA investigator flagged problems at the Baltimore facility six weeks before the Trump administration announced a $628 million deal with Emergent as part of Operation Warp Speed, the government’s program at the time to develop and produce vaccines to fight the novel coronavirus.

Emergent secured deals totaling more than $740 million with Johnson & Johnson and AstraZeneca to produce vaccines for both companies at the Baltimore site.

The Post reported last year that Emergent had benefited from billions of dollars in federal contracts as health officials directed public spending toward the threat of bioterrorism attacks at the expense of some preparations for a pandemic.

Emergent’s Warp Speed deal was made as part of a long-standing contract between the company and the agency within the Department of Health and Human Services responsible for preparing for public health threats.

At the time of the award, that agency was led by Assistant Secretary Robert Kadlec. The Post previously reported that before joining the Trump administration, Kadlec was paid as a consultant to Emergent and formed a start-up company with Emergent’s chairman. Kadlec did not mention either role in a questionnaire about his career that he completed for the Senate when it considered his nomination by Trump in 2017. Kadlec and Emergent previously told The Post that Kadlec’s past work for Emergent had no bearing on the firm’s government contracts.

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/news/30404524

Australia sets national record for virus vaccinations in a day

InternationalApr 05. 2021

By Syndication Washington Post, Bloomberg · Thuy Ong

Australia says it has given nearly 80,000 people a virus vaccination to set a new single-day high, boosted by strong stockpiles.

A record 79,283 people received an initial dose on Thursday, the latest day that such data is available, Health Minister Greg Hunt told a press briefing on Sunday.

“The supply at this stage is looking strong,” he said. “Given the great and enormous global competition, the fact we have this domestic supply is fundamental.”

Australia has nearly eliminated local transmissions by closing its international border to non-residents, but occasional cases have leaked into the community from quarantine hotels where returned overseas travelers must isolate for 14 days. States have imposed several snap lockdowns in recent months to contain clusters.

Australia has met its principal targets for vaccination start dates, Hunt added, and wants to see everyone who wants a shot getting an initial dose by the end of October. More than 841,000 vaccinations have been completed across Australia as of Saturday evening, he added.

The government is behind on its vaccine rollout plans, Mark Butler of the opposition Australian Labor Party said Sunday. Prime Minister Scott Morrison had promised 4 million doses would be given by the end of March, Butler said.

Australian authorities said on Saturday they were working with the European Union and the U.K. to investigate the first local case of an unusual clotting in a patient after receiving the AstraZeneca Plc vaccine.

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/news/30404523

Phone numbers, personal information for 533 million Facebook users exposed online, report says

InternationalApr 05. 2021

By The Washington Post · Hannah Knowles

Personal information on more than 500 million Facebook users – previously leaked and now made more widely available – was shared online Saturday, according to the news site Insider, worrying experts who said the compromised data could make people more vulnerable to fraud.

Insider said it reviewed a sample of the leaked phone numbers, birth dates, biographical details and more and found that some data matched known Facebook users’ records. The Washington Post has not independently verified the information. Facebook said the leak involved “old” data stemming from a problem resolved in 2019, but the news still sparked renewed scrutiny of a social media giant previously dogged by high-profile concerns about data privacy.

“Bad actors will certainly use the information for social engineering, scamming, hacking and marketing,” tweeted Alon Gal, the co-founder of an Israeli cybercrime intelligence company called Hudson Rock, who flagged the release of the Facebook data Saturday. Social engineering involves getting access to people’s confidential information by gaining their trust rather than overcoming technical barriers – for example, by impersonating a tech support person.

“I have yet to see Facebook acknowledging this absolute negligence of your data,” Gal tweeted. Gal said the compromised data also included Facebook IDs, full names, locations, some email addresses, relationship statuses and other details.

Facebook did not immediately respond to questions Saturday evening, but company spokeswoman Liz Bourgeois tweeted Saturday that the leak detailed by Insider involved “old data that was previously reported on in 2019.”

“We found and fixed this issue in August 2019,” Bourgeouis wrote.

Insider said a Facebook spokesperson told the news organization that the data was scraped through a now-fixed vulnerability.

The breach affected more than 533 million users spanning 106 countries, according to Insider, and includes more than 32 million records for users in the United States.

Gal told The Washington Post that the leaked database was previously sold for tens of thousands of dollars and then circulated, selling for lower prices until it finally was offered at no charge.

Early this year, Gal said, someone built a bot that gave people access to the database for a fee – a development that made the trove of data “much more worrisome,” Gal tweeted at the time. Motherboard reported in January on that peddling of access in a “low-level cybercriminal forum.”

On Saturday a user posted on a forum offering the data free.

The Post messaged the user on the app Telegram and did not immediately hear back.

Facebook – the world’s most popular social media site, with well over 2 billion users – has drawn rebukes before for its handling of people’s data. In 2019, the Federal Trade Commission fined the company $5 billion, alleging that it misled users about how third parties such as advertisers were accessing their personal information. Facebook did not have to admit guilt, but its settlement with the government included what was the largest privacy violation fine in American history.

The FTC began investigating after reports that Cambridge Analytica, a firm that worked with the campaign of former president Donald Trump, had improperly accessed names, “likes” and other information for millions of users without their knowledge.

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/news/30404522

Johnson & Johnson says it will take full control of its coronavirus vaccine production at Baltimore plant

InternationalApr 05. 2021

By The Washington Post · Jon Swaine

Johnson & Johnson will take full control of the production of its coronavirus vaccine at a troubled plant in Baltimore where millions of doses worth of drugs were contaminated, the company said late Saturday.

Production at the plant of the vaccine developed by AstraZeneca will be relocated with help from the Biden administration following the mix-up, according to AstraZeneca and a seniorfederal health official.

The developments followed the news that a batch amounting to 15 million doses of Johnson & Johnson’s vaccine was spoiled at the plant after being contaminated with ingredients for AstraZeneca’s vaccine.

The error was caught and no contaminated drugs made it out of the plant, according to the companies involved.

The plant is operated by Emergent BioSolutions, a major government contractor. The senior health official said the administration had determined that only one vaccine should be made at the facility.

Johnson & Johnson said in a statement that it was “assuming full responsibility” of production of its vaccine at the plant and that it was sending additional staff to Baltimore to oversee production.

“Specifically, the company is adding dedicated leaders for operations and quality, and significantly increasing the number of manufacturing, quality and technical operations personnel to work with the company specialists already at Emergent,” the statement said.

AstraZeneca said in a statement that it was working with the government to find an alternative location for production of its vaccine, which has not yet been authorized by U.S. authorities.

“AstraZeneca and the U.S. government continue to work closely together to support agreed upon plans for the development, production and full delivery of the vaccine,” the statement said.

Johnson & Johnson said that it still expected to deliver 100 million doses of its single-shot vaccine to the U.S. government by the end of May. President Biden has pledged that all American adults will be eligible for vaccination by that time.

Emergent spokeswoman Nina DeLorenzo confirmed Saturday that the company had been notified that production of the AstraZeneca vaccine would be relocated and that Emergent intended to stop making the vaccine in the next few days.

“We are welcoming additional Johnson & Johnson personnel on-site at Bayview for their technical expertise and support,” DeLorenzo said.

The changes in vaccine production at the plant were first reported Saturday by the New York Times.

Emergent’s coronavirus vaccine production line has not yet been certified by the Food and Drug Administration. Until it is certified, vaccines made there cannot be distributed to consumers. Drugs made at the Baltimore plant have been set aside while the FDA reviews the Emergent plant.

The Washington Post reported on Thursday that an FDA investigator flagged problems at the Baltimore facility six weeks before the Trump administration announced a $628 million deal with Emergent as part of Operation Warp Speed, the government’s program to rapidly produce vaccines to fight the novel coronavirus.

Emergent secured deals totaling more than $740 million with Johnson & Johnson and AstraZeneca to produce vaccines for both companies at the Baltimore site.

The Post reported last year that Emergent had benefited from billions of dollars in federal contracts as health officials directed public spending toward the threat of bioterrorism attacks at the expense of some preparations for a pandemic.

Emergent’s Warp Speed deal was made as part of a long-standing contract between the company and the office in the Department for Health and Human Services responsible for preparing for public health threats.

At the time of the award, that office was led by Assistant Secretary Robert Kadlec. The Post previously reported that before joining the Trump administration, Kadlec was paid as a consultant to Emergent and formed a startup company with Emergent’s chairman. Kadlec did not mention either role in a questionnaire about his career that he completed for the Senate when it considered his nomination by Donald Trump in 2017. Kadlec and Emergent previously told The Post that Kadlec’s past work for Emergent had no bearing on the firm’s government contracts.